In Phase 1/2 results for 12 patients at least one year after receiving the cell therapy, zimislecel, Vertex Pharmaceuticals reported all participants achieved blood glucose in the target range and 10 of the 12 were free of exogenous insulin as of the data cutoff. Vertex expects to complete enrollment in the pivotal portion of the…
Climate change not only impacts patients with respiratory allergies, but it also has potential broad and emerging impacts on patients with food allergies and overall public health. The post The Overlooked Global Warming Cost We Can’t Ignore appeared first on MedCity News.
The resilience of Medicaid lies in its complexity. It has resisted large-scale restructuring because it is interwoven with public and private delivery systems. That same complexity now demands a different kind of legal engagement. Medicaid is no longer a silo, but a system-defining platform. The post The Medicaid Reckoning: Era of Fiscal and Policy Flux…
Cohere Health introduced a new tool for payers called Review Assist. It is meant to support health plan clinical staff with prior authorization reviews and other use cases. The post New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers appeared first on MedCity News.
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup. The post Why Intermountain Health Is Investing In AI for Clinical Data Abstraction appeared first on MedCity News.
To be clear, this doesn’t mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity…
It’s a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain. The post The MFN Executive Order: A Global Reset for U.S. Pharma appeared first on MedCity News.
Just a year after its launch, Bluebird Kids Health is already announcing plans to double its number of pediatric clinics. The startup seeks to improve pediatric care access in underserved areas by building practices in these neighborhoods and accepting all insurance types. The post Bluebird Kids Health to Expand By Opening New Pediatric Clinics appeared…
Sword Health’s $40 million funding round was led by General Catalyst. In total, the company has raised $300 million. The most recent round brings its valuation to $4 billion. The post Sword Health Raises $40M, Launches Mental Health Solution appeared first on MedCity News.